Manufacturer of Controlled Substances; Notice of Registration, 28075-28076 [E7-9631]
Download as PDF
<![CDATA[
28075
Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: May 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9639 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated January 23, 2007, and
published in the Federal Register on
January 30, 2007, (72 FR 4298),
Mallinckrodt Inc., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule I and II:
pwalker on PROD1PC71 with NOTICES
Drug
Schedule
Codeine-N-oxide (9053) ...............
Difenoxin (9168) ...........................
Dihydromorphine (9145) ...............
Morphine-N-oxide (9307) .............
Norlevorphanol (9634) ..................
Normorphine (9313) .....................
Tetrahydrocannabinols (7370) .....
Nabilone (7379) ............................
Alfentanil(9737) ............................
Amphetamine (1100) ....................
Ecgonine (9180) ...........................
Codeine (9050) .............................
Dextropropoxyphene, bulk(9273)
Dihydrocodeine (9120) .................
Diphenoxylate (9170) ...................
Diprenorphine (9058) ...................
Etorphine HCL (9059) ..................
Fentanyl(9801) .............................
Hydrocodone (9193) .....................
VerDate Aug<31>2005
17:06 May 17, 2007
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 211001
Drug
Schedule
Hydromorphone (9150) ................
Levo-alphacetylmethadol (9648) ..
Levorphanol(9220) .......................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Metopon (9260) ............................
Morphine (9300) ...........................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium, granulated (9640) ............
Opium, powdered (9639) .............
Oxycodone (9143) ........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Phenazocine (9715) .....................
Alfentanil(9737) ............................
Remifentanil (9739) ......................
Sufentanil(9740) ...........................
Thebaine (9333) ...........................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The firm plans to manufacture the
listed controlled substances for internal
use and for sale to other companies.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Mallinckrodt Inc. to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated
Mallinckrodt Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9619 Filed 5–17–07; 8:45 am]
Mallinckrodt Inc., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Mallinckrodt Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Mallinckrodt Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9635 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated February 5, 2007 and
published in the Federal Register on
February 12, 2007, (72 FR 6579),
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
By Notice dated August 15, 2006, and
published in the Federal Register on
August 22, 2006, (71 FR 48947),
Noramco Inc., Division of OrthoMcNeil, Inc., 500 Old Swedes Landing
Road, Wilmington, Delaware 19801,
made application by renewal, and by
separate correspondence dated June 2,
E:\FR\FM\18MYN1.SGM
18MYN1
28076
Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
2006, and July 25, 2006, to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule I and II:
Drug
Schedule
Codeine-N-Oxide (9053) ..............
Morphine-N-Oxide (9307) .............
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Dihydromorphine (9145) ...............
Hydrocodone (9193) .....................
Thebaine (9333) ...........................
Morphine (9300) ...........................
Oxymorphone (9652) ...................
I
I
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the above listed controlled
substances for sale and distribution to
manufacturers for product development
and formulation.
By letter dated January 4, 2007,
Noramco has withdrawn their request
for Amphetamine (1100) and
Methylphenidate (1724).
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco Inc. to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33(a), the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: May 8, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9631 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Methylphenidate
(1724), a basic class of controlled
substance listed in schedule II.
The company plans to bulk
manufacture methylphenidate for a
customer to use in the production of a
controlled substance product.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco Inc. to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9651 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated December 14, 2006,
and published in the Federal Register
on December 22, 2006, (71 FR 77066),
Organichem Corporation, 33 Riverside
Avenue, Rensselaer, New York 12144,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
pwalker on PROD1PC71 with NOTICES
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Drug
By Notice dated July 26, 2006, and
published in the Federal Register on
August 2, 2006, (71 FR 43814), Noramco
VerDate Aug<31>2005
17:06 May 17, 2007
Jkt 211001
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Amphetamine (1100) ....................
Methylphenidate (1724) ................
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
I
I
II
II
Drug
Pentobarbital (2270) .....................
Hydrocodone (9193) .....................
Meperidine(9230) .........................
Dextropropoxyphene (9273) .........
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers.
In reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Organichem Corporation to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Organichem Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9612 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated January 16, 2007, and
published in the Federal Register on
January 23, 2007, (72 FR 2907), Organix
Inc., 240 Salem Street, Woburn,
Massachusetts 01801, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Pages 28075-28076]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9631]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 15, 2006, and published in the Federal
Register on August 22, 2006, (71 FR 48947), Noramco Inc., Division of
Ortho-McNeil, Inc., 500 Old Swedes Landing Road, Wilmington, Delaware
19801, made application by renewal, and by separate correspondence
dated June 2,
[[Page 28076]]
2006, and July 25, 2006, to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Codeine-N-Oxide (9053)..................... I
Morphine-N-Oxide (9307).................... I
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Dihydromorphine (9145)..................... II
Hydrocodone (9193)......................... II
Thebaine (9333)............................ II
Morphine (9300)............................ II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to bulk manufacture the above listed controlled
substances for sale and distribution to manufacturers for product
development and formulation.
By letter dated January 4, 2007, Noramco has withdrawn their
request for Amphetamine (1100) and Methylphenidate (1724).
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Noramco Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Noramco Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: May 8, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-9631 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P
